Automated molecule editing in molecular design

The ability to modify chemical structures in an automated and controlled manner is useful in molecular design. This Perspective introduces the MUDO molecule editor and shows how automated molecule editing can be used to standardize structures, enumerate tautomeric and ionization states, identify matched molecular pairs. Unlike its predecessor Leatherface, MUDO can also process 3D structures and this capability can be used to link non-covalently docked ligands to proteins.

[1]  The tautomerism of 1H‐pyrazole‐3(5)‐(N‐tert‐butyl)carboxamide in the solid state and in solution , 2005, Magnetic resonance in chemistry : MRC.

[2]  A. Renslo,et al.  Potency and selectivity of P2/P3-modified inhibitors of cysteine proteases from trypanosomes. , 2008, Bioorganic & medicinal chemistry letters.

[3]  J. Sangster,et al.  LOGKOW A Databank of Evaluated Octanol-Water Partition Coefficients , 1997 .

[4]  Visakan Kadirkamanathan,et al.  Lead Optimization Using Matched Molecular Pairs: Inclusion of Contextual Information for Enhanced Prediction of hERG Inhibition, Solubility, and Lipophilicity , 2010, J. Chem. Inf. Model..

[5]  Mark A. Murcko,et al.  Virtual screening : an overview , 1998 .

[6]  R. D. Bach,et al.  Strain energy of small ring hydrocarbons. Influence of C-h bond dissociation energies. , 2004, Journal of the American Chemical Society.

[7]  Jonas Boström,et al.  Oxadiazoles in medicinal chemistry. , 2012, Journal of medicinal chemistry.

[8]  J. Irwin,et al.  ZINC ? A Free Database of Commercially Available Compounds for Virtual Screening. , 2005 .

[9]  David L. Mobley,et al.  Chapter 4 Alchemical Free Energy Calculations: Ready for Prime Time? , 2007 .

[10]  N. Meanwell.  Synopsis of some recent tactical application of bioisosteres in drug design. , 2011, Journal of medicinal chemistry.

[11]  J. Wendoloski,et al.  Identification of compounds with nanomolar binding affinity for checkpoint kinase-1 using knowledge-based virtual screening. , 2004, Journal of medicinal chemistry.

[12]  S. Free,et al.  A MATHEMATICAL CONTRIBUTION TO STRUCTURE-ACTIVITY STUDIES. , 1964, Journal of medicinal chemistry.

[13]  Niklas Blomberg,et al.  Design of compound libraries for fragment screening , 2009, J. Comput. Aided Mol. Des..

[14]  P. Kenny,et al.  Matched molecular pair analysis of activity and properties of glycogen phosphorylase inhibitors. , 2009, Bioorganic & medicinal chemistry letters.

[15]  J. Bajorath,et al.  Activity landscape representations for structure-activity relationship analysis. , 2010, Journal of medicinal chemistry.

[16]  Peter J. Taylor,et al.  The tautomerism of 1,2,3-triazole in aqueous solution , 1989 .

[17]  G. Papadatos,et al.  In silico applications of bioisosterism in contemporary medicinal chemistry practice , 2013 .

[18]  Jennifer Legac,et al.  Vinyl Sulfones as Antiparasitic Agents and a Structural Basis for Drug Design* , 2009, The Journal of Biological Chemistry.

[19]  Daniel J. Warner,et al.  Matched molecular pairs as a medicinal chemistry tool. , 2011, Journal of medicinal chemistry.

[20]  Soraya S. Porres,et al.  5-Aminopyrimidin-2-ylnitriles as cathepsin K inhibitors. , 2009, Bioorganic & medicinal chemistry letters.

[21]  Z. Tian,et al.  Cycloalkane and cycloalkene C-H bond dissociation energies. , 2006, Journal of the American Chemical Society.

[22]  R. J. Herr,et al.  5-Substituted-1H-tetrazoles as carboxylic acid isosteres: medicinal chemistry and synthetic methods. , 2002, Bioorganic & medicinal chemistry.

[23]  Yvonne C. Martin,et al.  ALADDIN: An integrated tool for computer-assisted molecular design and pharmacophore recognition from geometric, steric, and substructure searching of three-dimensional molecular structures , 1989, J. Comput. Aided Mol. Des..

[24]  David Weininger,et al.  SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules , 1988, J. Chem. Inf. Comput. Sci..

[25]  Yvonne C. Martin,et al.  Let’s not forget tautomers , 2009, J. Comput. Aided Mol. Des..

[26]  A. L. L. East,et al.  pKa Values of Some Piperazines at (298, 303, 313, and 323) K , 2009 .

[27]  Daniel J. Warner,et al.  WizePairZ: A Novel Algorithm to Identify, Encode, and Exploit Matched Molecular Pairs with Unspecified Cores in Medicinal Chemistry , 2010, J. Chem. Inf. Model..

[28]  Robert P. Sheridan,et al.  The Most Common Chemical Replacements in Drug-Like Compounds , 2002, J. Chem. Inf. Comput. Sci..

[29]  Jürgen Bajorath,et al.  Exploring activity cliffs in medicinal chemistry. , 2012, Journal of medicinal chemistry.

[30]  Jens Sadowski,et al.  Structure Modification in Chemical Databases , 2005 .

[31]  Alfred A. Rabow,et al.  Enantiomeric pairs reveal that key medicinal chemistry parameters vary more than simple physical property based models can explain , 2012 .

[32]  Andrew G. Leach,et al.  Matched molecular pair analysis in drug discovery. , 2013, Drug discovery today.

[33]  Paul A. Bartlett,et al.  Caveat a program to facilitate the structure derived design of biologically active molecules , 1989 .

[34]  M. A. Fabian,et al.  BASICITIES OF CYCLOALKYLAMINES : BAEYER STRAIN THEORY REVISITED , 1999 .

[35]  T. Halgren.  MMFF VI. MMFF94s option for energy minimization studies , 1999, J. Comput. Chem..

[36]  Benjamin A. Ellingson,et al.  Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database , 2010, J. Chem. Inf. Model..

[37]  Andrew G. Leach,et al.  Matched molecular pairs as a guide in the optimization of pharmaceutical properties; a study of aqueous solubility, plasma protein binding and oral exposure. , 2006, Journal of medicinal chemistry.

[38]  José Elguero,et al.  The Tautomerism of heterocycles , 1976 .

[39]  Robert D Clark,et al.  Neighborhood behavior: a useful concept for validation of "molecular diversity" descriptors. , 1996, Journal of medicinal chemistry.

[40]  Jennifer R. Krumrine,et al.  Statistical tools for virtual screening. , 2005, Journal of medicinal chemistry.

[41]  Gerald M. Maggiora,et al.  On Outliers and Activity Cliffs-Why QSAR Often Disappoints , 2006, J. Chem. Inf. Model..

[42]  Jameed Hussain,et al.  Computationally Efficient Algorithm to Identify Matched Molecular Pairs (MMPs) in Large Data Sets , 2010, J. Chem. Inf. Model..

[43]  C. Thornber,et al.  Isosterism and molecular modification in drug design , 1979 .

[44]  Carlos Chagas,et al.  Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem , 1909 .

[45]  Schmid,et al.  "Scaffold-Hopping" by Topological Pharmacophore Search: A Contribution to Virtual Screening. , 1999, Angewandte Chemie.

[46]  R. Zwanzig.  High‐Temperature Equation of State by a Perturbation Method. I. Nonpolar Gases , 1954 .

[47]  Anne Mai Wassermann,et al.  Advances in Computational Medicinal Chemistry: Matched Molecular Pair Analysis , 2012 .

[48]  David Weininger,et al.  SMILES. 2. Algorithm for generation of unique SMILES notation , 1989, J. Chem. Inf. Comput. Sci..

[49]  E. LaVoie,et al.  Bioisosterism: A Rational Approach in Drug Design , 1997 .

[50]  Irwin Oppenheim,et al.  Statistical Mechanical Theory of Transport Processes. VII. The Coefficient of Thermal Conductivity of Monatomic Liquids , 1954 .

[51]  Roger A. Sayle,et al.  So you think you understand tautomerism? , 2010, J. Comput. Aided Mol. Des..

[52]  P. J. Taylor,et al.  Tautomeric ratio in 4-methylthiazol-2-ylguanidine, a model guanidinoheterocycle , 1985 .

[53]  L. Hammett.  The Effect of Structure upon the Reactions of Organic Compounds. Benzene Derivatives , 1937 .

[54]  J. McKerrow,et al.  Cysteine Protease Inhibitors Cure an Experimental Trypanosoma cruzi Infection , 1998, Journal of Experimental Medicine.

[55]  Jeffrey J Sutherland,et al.  Relating molecular properties and in vitro assay results to in vivo drug disposition and toxicity outcomes. , 2012, Journal of medicinal chemistry.

[56]  Paul M. Selzer,et al.  The Impact of Tautomer Forms on Pharmacophore-Based Virtual Screening , 2006, J. Chem. Inf. Model..

[57]  Sorel Muresan,et al.  Complementarity between public and commercial databases: new opportunities in medicinal chemistry informatics. , 2007, Current topics in medicinal chemistry.